e-learning
resources
Stockholm 2007
Monday 17.09.2007
Recent advances in our understanding of the mechanisms of asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma control and exhaled nitric oxide in asthmatic patients with severe obesity after weight loss
M. Maniscalco, A. Zedda, S. Faraone, M. R. Cerbone, S. Cristiano, C. Giardiello, M. Sofia (Casoria (Naples), Naples, Italy)
Source:
Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Session:
Recent advances in our understanding of the mechanisms of asthma treatment
Session type:
Thematic Poster Session
Number:
2165
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Maniscalco, A. Zedda, S. Faraone, M. R. Cerbone, S. Cristiano, C. Giardiello, M. Sofia (Casoria (Naples), Naples, Italy). Asthma control and exhaled nitric oxide in asthmatic patients with severe obesity after weight loss. Eur Respir J 2007; 30: Suppl. 51, 2165
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Exhaled nitric oxide in overweight and obese asthma patients compared to normal weight asthmatic patients.
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
Source: Eur Respir J 2010; 35: 1221-1227
Year: 2010
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008
Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
The relationship between exhaled nitric oxide and body mass index in controlled an uncontrolled Tunisian asthmatics
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008
Exhaled nitric oxide as a marker of asthma control in smoking patients
Source: Eur Respir J 2009; 33: 1295-1301
Year: 2009
Exhaled nitric oxide in infants: a marker of inflammation?
Source: Eur Respir Monogr 2010; 49: 56-70
Year: 2010
The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Low exhaled nitric oxide in severe uncomplicated obesity
Source: Eur Respir J 2006; 28: Suppl. 50, 864s
Year: 2006
Infant exhaled nitric oxide does not identify persistent wheezers by the age of four years
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study
Source: Eur Respir J 2011; 37: 523-531
Year: 2011
Exhaled nitric oxide and its role in monitoring asthma control in atopic children
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Exhaled nitric oxide in children with severe asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012
The influence of spirometry on the level of exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 569s
Year: 2003
Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence
Source: Eur Respir J 2016; 47: 510-519
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept